JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5551
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL ; volume:36 ; number:12 ; day:13 ; month:10 ; year:2022 ; pages:2802-2816 ; date:12.2022
Leukemia ; 36, Heft 12 (13.10.2022), 2802-2816, 12.2022
- Urheber
-
Benyoucef, Aissa
Haigh, Katharina
Cuddihy, Andrew
Haigh, Jody J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41375-022-01716-9
- URN
-
urn:nbn:de:101:1-2023021209153389275498
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benyoucef, Aissa
- Haigh, Katharina
- Cuddihy, Andrew
- Haigh, Jody J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Bedeutung von LSD1 und dem mit LSD1 interagierenden Protein SNAIL in Plattenepithelkarzinomen des Kopf-Hals-Bereichs (HNSCC)
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Bedeutung von LSD1 und dem mit LSD1 interagierenden Protein SNAIL in Plattenepithelkarzinomen des Kopf-Hals-Bereichs (HNSCC)
Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
LSD1 inhibition prolongs survival in mouse models of MPN by selectively targeting the Disease Clone
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria
GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro
The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2
Bcl2 inhibition of mitochondrial DNA repair
CD23-positive, BCL2-Rearrangement-negative Keimzentrumslymphome
BCL2 genotypes and prostate cancer survival
Bedeutung von LSD1 und dem mit LSD1 interagierenden Protein SNAIL in Plattenepithelkarzinomen des Kopf-Hals-Bereichs (HNSCC)